WHO approves Japan-made dengue vaccine

WHO approves TAK-003 (Qdenga) as 2nd dengue vaccine for children aged 6-16 in high-burden areas. Takeda in talks to launch in India. Panacea Biotec & Serum Institute collaborate on indigenous vaccine trials.